Allogene Therapeutics · 7 hours ago
SAP Data Specialist (Contract, Part-Time)
Allogene Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for cancer and autoimmune diseases. They are seeking a part-time SAP Data Specialist to manage master data within SAP and support report development, contributing to the efficiency of the supply chain operations.
BiotechnologyHealth DiagnosticsOncologyPharmaceutical
Responsibilities
Create and maintain Master Data elements in SAP Production, Quality and Development environments. (E.g., Material Master, BOMs, Recipes, Production Versions, Business Partner, Inspection Plans, etc.)
Participate in robust master data management and governance to ensure data integrity through accurate and complete master data
Create/maintain data related SOP’s, work instructions, forms, and training documents
Perform Change Control steps related to Master Data Change Actions
Provide Master Data Trainings and support to master data team members
Develop data definitions, data rules, and audit processes for each master data type with metrics for monitoring data accuracy and completeness
Develop and deliver impactful reports, identifying new reporting needs, and maintaining thorough documentation for ongoing support and enhancements
Use technology to enable efficiency, process robustness, and advanced analytics
Other duties as assigned
Qualification
Required
5+ years of experience in SAP Master Data Management
Proven change management and project management competency
A strong understanding of SAP and Master Data as it relates to manufacturing and supply chain from both a business and technical perspective
Experience with processes and solutions for Master Data Governance
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
Ability to work independently and as part of a team
Strong interpersonal skills including verbal and written communication are essential in this collaborative work environment
Candidates must reside in and be authorized to work in the U.S
Preferred
Experience in a pharmaceutical or similarly regulated industry
Company
Allogene Therapeutics
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Funding
Current Stage
Public CompanyTotal Funding
$891.77MKey Investors
Perceptive Advisors
2024-05-13Post Ipo Equity· $110M
2019-11-01Post Ipo Equity· $250M
2018-10-11IPO
Leadership Team
Recent News
2025-12-16
2025-12-16
Company data provided by crunchbase